Researchers at the University of East Anglia recommend that pregnant women with type 1 diabetes should have access to automated insulin delivery. This technology, called ‘hybrid closed-loop technology,’ uses a smartphone algorithm to give insulin doses. A study shows that this technology can help pregnant women manage their blood sugar levels better compared to traditional insulin pumps or daily injections. Complications related to type 1 diabetes during pregnancy are common, including premature birth, intensive care for the baby after birth, and overweight or obesity later in life. The researchers wanted to investigate how automated insulin delivery could help. The technology, known as Hybrid Closed-Loop or Artificial Pancreas, adjusts insulin doses every 10-12 minutes based on blood sugar levels. The study involved 124 pregnant women with type 1 diabetes who managed their condition with daily insulin therapy. The technology helped reduce maternal blood sugars throughout pregnancy and allowed women to spend more time in the target blood sugar range. Women using the technology also gained less weight and had fewer blood pressure complications during pregnancy. It also led to fewer clinic appointments and out-of-hours calls. The study’s results are specific to the CamAPS technology and cannot be applied to other closed-loop systems used during pregnancy. The research was funded by the Efficacy and Mechanism Evaluation Program and supported by the Juvenile Diabetes Research Foundation and the Diabetes Research & Wellness Foundation. The study was conducted by a collaboration of researchers from various institutions.
>>Join our Facebook Group be part of community. <<